Revance Therapeutics, Inc.

DB:RTI Stock Report

Market Cap: €372.8m

Revance Therapeutics, Inc. Company Information

Revance Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Revance Therapeutics, Inc.
  • Ticker: RTI
  • Exchange: DB
  • Founded: 1999
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$391.286m
  • Listing Market Cap: US$372.817m
  • Shares Outstanding: 104.90m
  • Website: https://www.revance.com

Number of Employees

Location

  • Revance Therapeutics, Inc.
  • 1222 Demonbreun Street
  • Suite 2000
  • Nashville
  • Tennessee
  • 37203
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RVNCNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDFeb 2014
RTIDB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 09:55
End of Day Share Price 2024/11/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.